APO Research

APO RESEARCH · REPORT

Necrotizing Ulcerative Gingivitis (NUG)

Selected research

Market Structure

Global Necrotizing Ulcerative Gingivitis (NUG) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Necrotizing Ulcerative Gingivitis (NUG) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Necrotizing Ulcerative Gingivitis (NUG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Necrotizing Ulcerative Gingivitis (NUG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Necrotizing Ulcerative Gingivitis (NUG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Necrotizing Ulcerative Gingivitis (NUG) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Necrotizing Ulcerative Gingivitis (NUG) include Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics, Otsuka Pharmaceutical, GlaxoSmithKline, Mylan, Merck, Novartis and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Necrotizing Ulcerative Gingivitis (NUG) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Necrotizing Ulcerative Gingivitis (NUG) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Necrotizing Ulcerative Gingivitis (NUG) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Necrotizing Ulcerative Gingivitis (NUG) market size, projected growth trends, production technologies, key applications, and end-use industries.

Necrotizing Ulcerative Gingivitis (NUG) Segment by Company

Abbott Laboratories

Eli Lilly and Company

Hindustan Antibiotics

Otsuka Pharmaceutical

GlaxoSmithKline

Mylan

Merck

Novartis

Sanofi

Teva Pharmaceutical

Necrotizing Ulcerative Gingivitis (NUG) Segment by Type

Medication

Surgery

Necrotizing Ulcerative Gingivitis (NUG) Segment by Application

Homecare

Pharmacies

Hospitals

Others

Necrotizing Ulcerative Gingivitis (NUG) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Necrotizing Ulcerative Gingivitis (NUG) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Necrotizing Ulcerative Gingivitis (NUG) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Necrotizing Ulcerative Gingivitis (NUG).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Necrotizing Ulcerative Gingivitis (NUG) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Necrotizing Ulcerative Gingivitis (NUG) industry.

Chapter 3: Detailed analysis of Necrotizing Ulcerative Gingivitis (NUG) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Necrotizing Ulcerative Gingivitis (NUG)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Medication Table 3. Key Players of Surgery Table 4. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Homecare Table 6. Key Players of Pharmacies Table 7. Key Players of Hospitals Table 8. Key Players of Others Table 9. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Necrotizing Ulcerative Gingivitis (NUG) Market Share by Region (2021-2026) Table 12. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Necrotizing Ulcerative Gingivitis (NUG) Market Share by Region (2027-2032) Table 14. Necrotizing Ulcerative Gingivitis (NUG) Industry Trends Table 15. Necrotizing Ulcerative Gingivitis (NUG) Industry Drivers Table 16. Necrotizing Ulcerative Gingivitis (NUG) Industry Opportunities and Challenges Table 17. Necrotizing Ulcerative Gingivitis (NUG) Industry Restraints Table 18. Global Necrotizing Ulcerative Gingivitis (NUG) Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Necrotizing Ulcerative Gingivitis (NUG) Revenue Market Share by Company (2021-2026) Table 20. Global Necrotizing Ulcerative Gingivitis (NUG) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Necrotizing Ulcerative Gingivitis (NUG) Key Company Head Office and Area Served Table 22. Global Necrotizing Ulcerative Gingivitis (NUG) Company, Product Type & Application Table 23. Global Necrotizing Ulcerative Gingivitis (NUG) Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Necrotizing Ulcerative Gingivitis (NUG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Necrotizing Ulcerative Gingivitis (NUG) Revenue Market Share by Type (2021-2026) Table 30. Global Necrotizing Ulcerative Gingivitis (NUG) Revenue Market Share by Type (2027-2032) Table 31. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Necrotizing Ulcerative Gingivitis (NUG) Revenue Market Share by Application (2021-2026) Table 35. Global Necrotizing Ulcerative Gingivitis (NUG) Revenue Market Share by Application (2027-2032) Table 36. Abbott Laboratories Company Information Table 37. Abbott Laboratories Business Overview Table 38. Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio Table 40. Abbott Laboratories Recent Development Table 41. Eli Lilly and Company Company Information Table 42. Eli Lilly and Company Business Overview Table 43. Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio Table 45. Eli Lilly and Company Recent Development Table 46. Hindustan Antibiotics Company Information Table 47. Hindustan Antibiotics Business Overview Table 48. Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio Table 50. Hindustan Antibiotics Recent Development Table 51. Otsuka Pharmaceutical Company Information Table 52. Otsuka Pharmaceutical Business Overview Table 53. Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio Table 55. Otsuka Pharmaceutical Recent Development Table 56. GlaxoSmithKline Company Information Table 57. GlaxoSmithKline Business Overview Table 58. GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio Table 60. GlaxoSmithKline Recent Development Table 61. Mylan Company Information Table 62. Mylan Business Overview Table 63. Mylan Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Mylan Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio Table 65. Mylan Recent Development Table 66. Merck Company Information Table 67. Merck Business Overview Table 68. Merck Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Merck Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio Table 70. Merck Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Novartis Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio Table 75. Novartis Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Sanofi Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio Table 80. Sanofi Recent Development Table 81. Teva Pharmaceutical Company Information Table 82. Teva Pharmaceutical Business Overview Table 83. Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio Table 85. Teva Pharmaceutical Recent Development Table 86. North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026) & (US$ Million) Table 87. North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032) & (US$ Million) Table 88. North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026) & (US$ Million) Table 89. North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032) & (US$ Million) Table 90. North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026) Table 92. North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2027-2032) Table 93. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026) & (US$ Million) Table 94. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032) & (US$ Million) Table 95. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026) & (US$ Million) Table 96. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032) & (US$ Million) Table 97. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026) Table 99. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2027-2032) Table 100. China Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026) & (US$ Million) Table 101. China Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032) & (US$ Million) Table 102. China Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026) & (US$ Million) Table 103. China Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026) & (US$ Million) Table 105. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032) & (US$ Million) Table 106. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026) & (US$ Million) Table 107. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032) & (US$ Million) Table 108. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026) Table 110. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2027-2032) Table 111. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026) & (US$ Million) Table 112. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032) & (US$ Million) Table 113. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026) Table 117. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Necrotizing Ulcerative Gingivitis (NUG) Product Image Figure 2. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type: 2025 VS 2032 Figure 4. Medication Image Figure 5. Surgery Image Figure 6. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application: 2025 VS 2032 Figure 8. Homecare Image Figure 9. Pharmacies Image Figure 10. Hospitals Image Figure 11. Others Image Figure 12. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 14. Global Necrotizing Ulcerative Gingivitis (NUG) Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Necrotizing Ulcerative Gingivitis (NUG) Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Necrotizing Ulcerative Gingivitis (NUG) Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Necrotizing Ulcerative Gingivitis (NUG) Revenue Market Share by Type (2021-2032) Figure 21. Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Necrotizing Ulcerative Gingivitis (NUG) Revenue Market Share by Application (2021-2032) Figure 23. North America Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 24. North America Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type (2021-2032) Figure 25. North America Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application (2021-2032) Figure 26. North America Necrotizing Ulcerative Gingivitis (NUG) Market Share by Country (2021-2032) Figure 27. United States Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 28. Canada Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 30. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 31. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type (2021-2032) Figure 32. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application (2021-2032) Figure 33. Europe Necrotizing Ulcerative Gingivitis (NUG) Market Share by Country (2021-2032) Figure 34. Germany Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 35. France Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 37. Italy Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 38. Russia Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 40. China Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 41. China Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type (2021-2032) Figure 42. China Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application (2021-2032) Figure 43. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 44. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type (2021-2032) Figure 45. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application (2021-2032) Figure 46. Asia Necrotizing Ulcerative Gingivitis (NUG) Market Share by Country (2021-2032) Figure 47. Japan Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 51. India Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 52. Australia Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Share by Country (2021-2032) Figure 57. Brazil Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 62. UAE Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 64. Chile Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Medication
  • Surgery
Applications
  • Homecare
  • Pharmacies
  • Hospitals
  • Others
Companies covered
  • Abbott Laboratories
  • Eli Lilly and Company
  • Hindustan Antibiotics
  • Otsuka Pharmaceutical
  • GlaxoSmithKline
  • Mylan
  • Merck
  • Novartis
  • Sanofi
  • Teva Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Medication
  5. 1.2.3 Surgery
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Homecare
  9. 1.3.3 Pharmacies
  10. 1.3.4 Hospitals
  11. 1.3.5 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Necrotizing Ulcerative Gingivitis (NUG) Growth Trends by Region
  14. 1.5.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region (2021-2026)
  16. 1.5.3 Necrotizing Ulcerative Gingivitis (NUG) Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Necrotizing Ulcerative Gingivitis (NUG) Market Dynamics
  1. 2.1 Necrotizing Ulcerative Gingivitis (NUG) Industry Trends
  2. 2.2 Necrotizing Ulcerative Gingivitis (NUG) Industry Drivers
  3. 2.3 Necrotizing Ulcerative Gingivitis (NUG) Industry Opportunities and Challenges
  4. 2.4 Necrotizing Ulcerative Gingivitis (NUG) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Necrotizing Ulcerative Gingivitis (NUG) Revenue by Company (2021-2026)
  2. 3.2 Global Necrotizing Ulcerative Gingivitis (NUG) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Necrotizing Ulcerative Gingivitis (NUG) Key Company Head office and Area Served
  4. 3.4 Global Necrotizing Ulcerative Gingivitis (NUG) Company, Product Type & Application
  5. 3.5 Global Necrotizing Ulcerative Gingivitis (NUG) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Necrotizing Ulcerative Gingivitis (NUG) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Necrotizing Ulcerative Gingivitis (NUG) Tier 1, Tier 2, and Tier 3
4 Necrotizing Ulcerative Gingivitis (NUG) Market by Type
  1. 4.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2032)
  3. 4.3 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Share by Type (2021-2032)
5 Necrotizing Ulcerative Gingivitis (NUG) Market by Application
  1. 5.1 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2032)
  3. 5.3 Global Necrotizing Ulcerative Gingivitis (NUG) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbott Laboratories Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 Eli Lilly and Company
  8. 6.2.1 Eli Lilly and Company Company Information
  9. 6.2.2 Eli Lilly and Company Business Overview
  10. 6.2.3 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eli Lilly and Company Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
  12. 6.2.5 Eli Lilly and Company Recent Developments
  13. 6.3 Hindustan Antibiotics
  14. 6.3.1 Hindustan Antibiotics Company Information
  15. 6.3.2 Hindustan Antibiotics Business Overview
  16. 6.3.3 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Hindustan Antibiotics Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
  18. 6.3.5 Hindustan Antibiotics Recent Developments
  19. 6.4 Otsuka Pharmaceutical
  20. 6.4.1 Otsuka Pharmaceutical Company Information
  21. 6.4.2 Otsuka Pharmaceutical Business Overview
  22. 6.4.3 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Otsuka Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
  24. 6.4.5 Otsuka Pharmaceutical Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 GlaxoSmithKline Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Mylan
  32. 6.6.1 Mylan Company Information
  33. 6.6.2 Mylan Business Overview
  34. 6.6.3 Mylan Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Mylan Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
  36. 6.6.5 Mylan Recent Developments
  37. 6.7 Merck
  38. 6.7.1 Merck Company Information
  39. 6.7.2 Merck Business Overview
  40. 6.7.3 Merck Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Merck Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
  42. 6.7.5 Merck Recent Developments
  43. 6.8 Novartis
  44. 6.8.1 Novartis Company Information
  45. 6.8.2 Novartis Business Overview
  46. 6.8.3 Novartis Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Novartis Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
  48. 6.8.5 Novartis Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sanofi Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
  55. 6.10 Teva Pharmaceutical
  56. 6.10.1 Teva Pharmaceutical Company Information
  57. 6.10.2 Teva Pharmaceutical Business Overview
  58. 6.10.3 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Teva Pharmaceutical Necrotizing Ulcerative Gingivitis (NUG) Product Portfolio
  60. 6.10.5 Teva Pharmaceutical Recent Developments
7 North America
  1. 7.1 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032)
  2. 7.2 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type
  3. 7.2.1 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026)
  4. 7.2.2 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032)
  5. 7.2.3 North America Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type (2021-2032)
  6. 7.3 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application
  7. 7.3.1 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026)
  8. 7.3.2 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032)
  9. 7.3.3 North America Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application (2021-2032)
  10. 7.4 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country
  11. 7.4.1 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026)
  13. 7.4.3 North America Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2027-2032)
  14. 7.4.4 North America Necrotizing Ulcerative Gingivitis (NUG) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032)
  2. 8.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type
  3. 8.2.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type (2021-2032)
  6. 8.3 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application
  7. 8.3.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application (2021-2032)
  10. 8.4 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country
  11. 8.4.1 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Necrotizing Ulcerative Gingivitis (NUG) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032)
  2. 9.2 China Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type
  3. 9.2.1 China Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026)
  4. 9.2.2 China Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032)
  5. 9.2.3 China Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type (2021-2032)
  6. 9.3 China Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application
  7. 9.3.1 China Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026)
  8. 9.3.2 China Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032)
  9. 9.3.3 China Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032)
  2. 10.2 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type
  3. 10.2.1 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type (2021-2032)
  6. 10.3 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application
  7. 10.3.1 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application (2021-2032)
  10. 10.4 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country
  11. 10.4.1 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Necrotizing Ulcerative Gingivitis (NUG) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Necrotizing Ulcerative Gingivitis (NUG) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research